Clinical Trial

TENS and Opioid Use After Cesarean Delivery

Study Description

TENS and Opioid Use After Cesarean Delivery

We propose to explore the effects of Transcutaneous Electrical Nerve Stimulation (TENS) therapy in the pain management of postpartum women. A. Objectives - To determine if the addition of TENS therapy to the pain management of women post-cesarean section leads to less opioid medication use. - To evaluate the efficacy of TENS therapy as a means of alternative pain relief for women post-cesarean section with a history of opioid use. B. Hypotheses / Research Question(s) We hypothesize that patients that receive TENS therapy will report lower pain scores and request less opioid medication than the control group. We anticipate improved control in particular in the group of women with a history of opioid use. Additionally, we believe that the TENS therapy will show benefits in other postpartum outcomes including time to bowel movement, level of sedation, and time to out of bed. Overall, we anticipate that this pilot study will support the application of TENS therapy in postpartum pain management.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Device - Transcutaneous Electrical Nerve Stimulation (TENS)

Starting 8 hours after cesarean section, the TENS unit will be applied with charges above and below the incision. The device will be set to high frequency (>75 Hz) for pain relief. Intensity of stimulation will be set to patient threshold using the forearm as a guide. Stimulation will be turned on titrated to the level which is felt but not painful for the patient. It will remain on until the patient is discharged, to be removed for toilet and showering at the patient's discretion. Once the TENS ...read more on ClinicalTrials.org

Additional Information

Official Study Title

Transcutaneous Electrical Nerve Stimulation and Maternal Opioid Use After Cesarean Delivery

Clinical Trial ID

NCT03843788

ParticipAid ID

b2kJjd